Sex hormone-binding globulin and risk of type 2 diabetes in women and men
- PMID: 19657112
- PMCID: PMC2774225
- DOI: 10.1056/NEJMoa0804381
Sex hormone-binding globulin and risk of type 2 diabetes in women and men
Abstract
Background: Circulating sex hormone-binding globulin levels are inversely associated with insulin resistance, but whether these levels can predict the risk of developing type 2 diabetes is uncertain.
Methods: We performed a nested case-control study of postmenopausal women in the Women's Health Study who were not using hormone therapy (359 with newly diagnosed type 2 diabetes and 359 controls). Plasma levels of sex hormone-binding globulin were measured; two polymorphisms of the gene encoding sex hormone-binding globulin, SHBG, that were robustly associated with the protein levels were genotyped and applied in mendelian randomization analyses. We then conducted a replication study in an independent cohort of men from the Physicians' Health Study II (170 with newly diagnosed type 2 diabetes and 170 controls).
Results: Among women, higher plasma levels of sex hormone-binding globulin were prospectively associated with a lower risk of type 2 diabetes: multivariable odds ratios were 1.00 for the first (lowest) quartile of plasma levels, 0.16 (95% confidence interval [CI], 0.08 to 0.33) for the second quartile, 0.04 (95% CI, 0.01 to 0.12) for the third quartile, and 0.09 (95% CI, 0.03 to 0.21) for the fourth (highest) quartile (P<0.001 for trend). These prospective associations were replicated among men (odds ratio for the highest quartile of plasma levels vs. the lowest quartile, 0.10; 95% CI, 0.03 to 0.36; P<0.001 for trend). As compared with homozygotes of the respective wild-type allele, carriers of a variant allele of the SHBG single-nucleotide polymorphism (SNP) rs6259 had 10% higher sex hormone-binding globulin levels (P=0.005), and carriers of an rs6257 variant had 10% lower plasma levels (P=0.004); variants of both SNPs were also associated with a risk of type 2 diabetes in directions corresponding to their associated sex hormone-binding globulin levels. In mendelian randomization analyses, the predicted odds ratio of type 2 diabetes per standard-deviation increase in the plasma level of sex hormone-binding globulin was 0.28 (95% CI, 0.13 to 0.58) among women and 0.29 (95% CI, 0.15 to 0.58) among men, a finding that suggests that sex hormone-binding globulin may have a causal role in the risk of type 2 diabetes.
Conclusions: Low circulating levels of sex hormone-binding globulin are a strong predictor of the risk of type 2 diabetes in women and men. The clinical usefulness of both SHBG genotypes and plasma levels in stratification and intervention for the risk of type 2 diabetes warrants further examination.
2009 Massachusetts Medical Society
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2774225/bin/nihms140123f1.gif)
Comment in
-
Sex hormone-binding globulin and risk of type 2 diabetes.N Engl J Med. 2009 Dec 31;361(27):2675-6; author reply 2677-8. doi: 10.1056/NEJMc0910143. N Engl J Med. 2009. PMID: 20042761 No abstract available.
-
Sex hormone-binding globulin and risk of type 2 diabetes.N Engl J Med. 2009 Dec 31;361(27):2677; author reply 2677-8. N Engl J Med. 2009. PMID: 20050387 No abstract available.
-
Sex hormone-binding globulin and risk of type 2 diabetes.N Engl J Med. 2009 Dec 31;361(27):2676-7; author reply 2677-8. N Engl J Med. 2009. PMID: 20050388 No abstract available.
Similar articles
-
Sex hormone-binding globulin genetic variation: associations with type 2 diabetes mellitus and polycystic ovary syndrome.Minerva Endocrinol. 2010 Dec;35(4):271-80. Minerva Endocrinol. 2010. PMID: 21178921 Free PMC article. Review.
-
Coffee and caffeine consumption in relation to sex hormone-binding globulin and risk of type 2 diabetes in postmenopausal women.Diabetes. 2011 Jan;60(1):269-75. doi: 10.2337/db10-1193. Epub 2010 Oct 28. Diabetes. 2011. PMID: 21030499 Free PMC article. Clinical Trial.
-
Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes.Hum Mol Genet. 2010 Feb 1;19(3):535-44. doi: 10.1093/hmg/ddp522. Epub 2009 Nov 18. Hum Mol Genet. 2010. PMID: 19933169 Free PMC article.
-
Identification of common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal women.Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3490-8. doi: 10.1158/1055-9965.EPI-08-0734. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 19064566 Free PMC article.
-
Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis.JAMA. 2006 Mar 15;295(11):1288-99. doi: 10.1001/jama.295.11.1288. JAMA. 2006. PMID: 16537739 Review.
Cited by
-
Blood lipid levels mediating the effects of sex hormone-binding globulin on coronary heart disease: Mendelian randomization and mediation analysis.Sci Rep. 2024 May 25;14(1):11993. doi: 10.1038/s41598-024-62695-8. Sci Rep. 2024. PMID: 38796576 Free PMC article.
-
Associations of sex hormone ratios with metabolic syndrome and inflammation in US adult men and women.Front Endocrinol (Lausanne). 2024 Apr 10;15:1384603. doi: 10.3389/fendo.2024.1384603. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38660513 Free PMC article.
-
INSULIN RESISTANCE AND PATHOGENESIS OF POSTMENOPAUSAL OSTEOPOROSIS.Acta Endocrinol (Buchar). 2023 Jul-Sep;19(3):349-363. doi: 10.4183/aeb.2023.349. Epub 2024 Feb 1. Acta Endocrinol (Buchar). 2023. PMID: 38356971 Free PMC article. Review.
-
Longitudinal Changes in Sex Hormone Binding Globulin (SHBG) and Risk of Incident Diabetes: The Study of Women's Health Across the Nation (SWAN).Diabetes Care. 2024 Apr 1;47(4):676-682. doi: 10.2337/dc23-1630. Diabetes Care. 2024. PMID: 38320264
-
Reproductive risk factors across the female lifecourse and later metabolic health.Cell Metab. 2024 Feb 6;36(2):240-262. doi: 10.1016/j.cmet.2024.01.002. Epub 2024 Jan 26. Cell Metab. 2024. PMID: 38280383 Review.
References
-
- Rosner W, Hryb DJ, Khan MS, Nakhla AM, Romas NA. Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane. J Steroid Biochem Mol Biol. 1999;69:481–5. - PubMed
-
- Hammes A, Andreassen TK, Spoelgen R, et al. Role of endocytosis in cellular uptake of sex steroids. Cell. 2005;122:751–62. - PubMed
-
- Porto CS, Lazari MF, Abreu LC, Bardin CW, Gunsalus GL. Receptors for androgen-binding proteins: internalization and intracellular signalling. J Steroid Biochem Mol Biol. 1995;53:561–5. - PubMed
-
- Fortunati N, Becchis M, Catalano MG, et al. Sex hormone-binding globulin, its membrane receptor, and breast cancer: a new approach to the modulation of estradiol action in neoplastic cells. J Steroid Biochem Mol Biol. 1999;69:473–9. - PubMed
-
- Kahn SM, Hryb DJ, Nakhla AM, Romas NA, Rosner W. Sex hormone-binding globulin is synthesized in target cells. J Endocrinol. 2002;175:113–20. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA040360-17/CA/NCI NIH HHS/United States
- K01-DK078846/DK/NIDDK NIH HHS/United States
- R01 CA047988-09/CA/NCI NIH HHS/United States
- R01 HL043851/HL/NHLBI NIH HHS/United States
- R01 CA047988-16/CA/NCI NIH HHS/United States
- R01 CA097193-02/CA/NCI NIH HHS/United States
- R01 CA097193-08/CA/NCI NIH HHS/United States
- CA047988/CA/NCI NIH HHS/United States
- R01 CA034944-03/CA/NCI NIH HHS/United States
- R01 CA047988-13/CA/NCI NIH HHS/United States
- R01 CA040360-16/CA/NCI NIH HHS/United States
- HL080467/HL/NHLBI NIH HHS/United States
- R01 CA034944/CA/NCI NIH HHS/United States
- R01 CA097193-05/CA/NCI NIH HHS/United States
- R01 HL080467-02/HL/NHLBI NIH HHS/United States
- R01 CA047988-15/CA/NCI NIH HHS/United States
- R01 CA097193-01/CA/NCI NIH HHS/United States
- R01 CA047988-14/CA/NCI NIH HHS/United States
- R01 HL034595/HL/NHLBI NIH HHS/United States
- R01 HL080467-01/HL/NHLBI NIH HHS/United States
- DK066401/DK/NIDDK NIH HHS/United States
- R01 CA097193-03/CA/NCI NIH HHS/United States
- CA097193/CA/NCI NIH HHS/United States
- R01 CA097193-07/CA/NCI NIH HHS/United States
- L30 DK084809/DK/NIDDK NIH HHS/United States
- R01 CA047988-17/CA/NCI NIH HHS/United States
- R01 HL043851-09/HL/NHLBI NIH HHS/United States
- R01 HL080467-04/HL/NHLBI NIH HHS/United States
- R01 HL026490/HL/NHLBI NIH HHS/United States
- R01 CA047988-10/CA/NCI NIH HHS/United States
- R01 CA047988/CA/NCI NIH HHS/United States
- R01 HL043851-10/HL/NHLBI NIH HHS/United States
- R01 CA097193-04/CA/NCI NIH HHS/United States
- R01 HL080467/HL/NHLBI NIH HHS/United States
- R01 DK066401/DK/NIDDK NIH HHS/United States
- R01 CA040360/CA/NCI NIH HHS/United States
- K01 DK078846/DK/NIDDK NIH HHS/United States
- R01 CA047988-11/CA/NCI NIH HHS/United States
- R01 CA047988-12/CA/NCI NIH HHS/United States
- R01 CA097193-06A1/CA/NCI NIH HHS/United States
- K01 DK078846-02/DK/NIDDK NIH HHS/United States
- R01 HL080467-03/HL/NHLBI NIH HHS/United States
- L30 DK084809-01/DK/NIDDK NIH HHS/United States
- R01 CA040360-14/CA/NCI NIH HHS/United States
- R01 CA097193/CA/NCI NIH HHS/United States
- CA40360/CA/NCI NIH HHS/United States
- R01 CA040360-15/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous